Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0979 per EA under NDC 68001015900. Its NADAC has been published 644 times since Feb 26, 2014.
Strength
50 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001015900
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077653On Market Since
11/25/2013
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 644 times since Feb 26, 2014, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0979 per EA |
|---|---|
| All-time high | $0.4628 (Feb 10, 2016) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.0979 |
| 52-week low | $0.0797 |
| Median price | $0.1872 |
| Average price | $0.2017 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 644 |
| Tracking since | Feb 26, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by BluePoint Laboratories, is $0.0979 per EA (NDC 68001015900), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 73.1%. It has been tracked across 644 weekly CMS publications since Feb 26, 2014.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Feb 26, 2014, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.4628 (Feb 10, 2016), with a median of $0.1872 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 68001015900) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification